Vincent Serra
Chief Operating Officer at NEOVACS
Network origin in Vincent Serra first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
13
| Public Company | Pharmaceuticals: Major | 13 |
Anosys, Inc.
 Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Wittycell SAS
 Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
BioSupport AG
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Vincent Serra via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Banks/Brokers | Director/Board Member | |
| AFFIMED N.V. | Biotechnology | Director of Finance/CFO | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Corporate Officer/Principal | |
Haarmann & Reimer Corp
 Haarmann & Reimer Corp Food: Specialty/CandyConsumer Non-Durables Haarmann & Reimer Corp is a German company that manufactures flavors and fragrances. The company is based in Holzminden, DE and has subsidiaries in the United States. Haarmann & Reimer was acquired by EQT III Fund from Bayer AG on October 01, 2002 for $1,676.85 million. | Food: Specialty/Candy | Chairman | |
| CYBERGUN | Recreational Products | Chief Executive Officer Chief Operating Officer | |
Ethypharm SAS
 Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | Pharmaceuticals: Major | Director/Board Member | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Sciences Po | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree | |
| Fondation de la Maison de la Chimie | Director/Board Member | ||
Truffle Capital SAS
 Truffle Capital SAS Investment ManagersFinance Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris. | Investment Managers | Private Equity Analyst Founder Private Equity Analyst | |
| DMS IMAGING | Biotechnology | Director/Board Member | |
Borchers SAS
 Borchers SAS Industrial SpecialtiesProcess Industries Borchers SAS produces paints, lacquers and polishes. The company is headquartered in Castres, France. | Industrial Specialties | Corporate Officer/Principal | |
| PHARNEXT SCA | Biotechnology | Founder Chief Executive Officer | |
Bayer SAS
 Bayer SAS Drugstore ChainsRetail Trade Bayer SAS engages in research, development and marketing of pharmaceutical products. The company was founded by Friedrich Bayer and Johann Friedrich Weskott in 1863 and is headquartered in Lyon, France. | Drugstore Chains | Chief Executive Officer | |
| Bayer Sante | Chairman | ||
ARLANXEO Elastomères France SAS
 ARLANXEO Elastomères France SAS Chemicals: SpecialtyProcess Industries ARLANXEO Elastomeres France manufactures synthetic rubber. It specializes in tires. The company was founded in 1961 and is headquartered in Lillebonne, France. | Chemicals: Specialty | Chairman | |
Lanxess SAS
 Lanxess SAS Chemicals: Major DiversifiedProcess Industries Part of Lanxess AG, Lanxess SAS is a French company that produces, develops, and markets chemical intermediates, additives, specialty chemicals, and plastics. The private company is based in Courbevoie, France. | Chemicals: Major Diversified | Director/Board Member | |
BiognoSYS AG
 BiognoSYS AG Packaged SoftwareTechnology Services BiognoSYS AG operates as a biotechnology company. Its products include iRT Kit, HRM Kit, Sample Prep Kit, PlasmaDive, Spectronaut and SpectroDive. The company was founded by Philipp M. Antoni, Johan Malmstroem and Oliver Rinner on September 3, 2008 and is headquartered in Schlieren, Switzerland. | Packaged Software | Chairman | |
Novaremed AG
 Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Pharmaceuticals: Major | Chairman | |
| Microtrade SARL | Corporate Officer/Principal Corporate Officer/Principal | ||
Cybergun International SA
 Cybergun International SA Financial ConglomeratesFinance Cybergun International SA is an investment holding Luxembourger company. The private company is based in Luxembourg, Luxembourg. | Financial Conglomerates | Director/Board Member Director/Board Member | |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Biotechnology | Chairman | |
IMD Laboratoires SARL
 IMD Laboratoires SARL Wholesale DistributorsDistribution Services IMD Laboratoires SARL distributes laboratory equipment and reagents. The private company is based in Algiers, Algeria. | Wholesale Distributors | Corporate Officer/Principal | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member | |
| ABIVAX | Pharmaceuticals: Other | Director/Board Member Founder Founder | |
| Bayer HealthCare Ltd. | Director/Board Member | ||
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| HBM Fondation | Corporate Officer/Principal | ||
| BOOSTHEAT | Industrial Machinery | Chief Executive Officer Director/Board Member | |
| Hbr Investment Group SAS | Chairman Chief Executive Officer | ||
Neovacs, Inc.
 Neovacs, Inc. Pharmaceuticals: MajorHealth Technology Neovacs, Inc. operates as a biotechnology company. It focuses on an active immunotherapy technology platform with applications in autoimmune and inflammatory diseases. The company was founded on March 3, 2015 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member President | |
Restarted Investment SA
 Restarted Investment SA Financial ConglomeratesFinance Restarted Investment SA functions as an investment holding Belgian company. The private company is based in Forest, Belgium. The CEO of the company is Baudouin Hallo. | Financial Conglomerates | Chairman Chief Executive Officer | |
Virometix AG
 Virometix AG Pharmaceuticals: MajorHealth Technology Virometix AG is a Swiss biotechnology company that focuses on developing vaccines and immunotherapeutic drugs for the prevention and treatment of infections and cancer. Virometix is based in Schlieren, CH. The private company's mission is to address the growing medical need for vaccines to combat infectious and chronic human diseases. The company was founded by John Anthony Robinson, and the CEO is Anna Sumeray. | Pharmaceuticals: Major | Chairman | |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The private company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Director/Board Member | |
| Dionae Investment SAS | Chairman Chief Executive Officer | ||
| HBR Flight Service S.A.S. | Chairman Chief Executive Officer | ||
Plasmaprime SAS
 Plasmaprime SAS Medical/Nursing ServicesHealth Services Plasmaprime SAS provides plasma derived drugs collected from blood transfusion centers. The company was founded by Heriberto Sieler and Philippe Pouletty on January 23, 2009 and is headquartered in Evry, France. | Medical/Nursing Services | Founder Chairman | |
Demeta SAS
 Demeta SAS BiotechnologyHealth Technology Demeta SAS operates as a research and Development in Biotechnology. The firm specializes in biological products, except diagnostic substances. The company was founded in April 4, 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Chairman | |
Natchem SAS
 Natchem SAS BiotechnologyHealth Technology NatChem SAS engages in research and development, which focuses on biotechnology. The company was founded on December 2011 and is headquartered in Paris, France. | Biotechnology | Chairman |
Statistics
International
| France | 28 |
| Switzerland | 10 |
| United States | 6 |
| Germany | 4 |
| Belgium | 3 |
Sectoral
| Health Technology | 18 |
| Finance | 6 |
| Consumer Services | 5 |
| Commercial Services | 4 |
| Process Industries | 4 |
Operational
| Director/Board Member | 115 |
| Chairman | 57 |
| Corporate Officer/Principal | 44 |
| Founder | 32 |
| Chief Executive Officer | 29 |
Most connected contacts
| Insiders | |
|---|---|
| Philippe Pouletty | 51 |
| Hugo Brugière | 33 |
| Arlene Morris | 28 |
| Miguel Sieler | 25 |
| Harry Welten | 22 |
| Jean-Jacques Bertrand | 21 |
| Baudouin Hallo | 16 |
| Philippe Maitre | 11 |
| Somesh Datt Sharma | 9 |
| Eszter Nagy | 8 |
| Nancy Valente | 8 |
| Daniel Zagury | 7 |
| Thérèse Croughs | 6 |
| Larry Braga | 5 |
| Valerie Salentey | 5 |
- Stock Market
- Insiders
- Vincent Serra
- Company connections